Drawing for HANCOL

USPTO serial 88064968

HANCOL

Reviewed by CopyMark Law Group

Reg. 6026480Status 710
Filing date
Status date
Registration date
Apr 7, 2020
Examiner
HESIK, APRIL ANNE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with HANCOL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David Youngjoon Jung

David Youngjoon Jung KAIROS Law Firm, PLLC2001 L Street N.W. Suite 500Washington, DC 20036United States

Goods and services

ClassDescriptionStatusFirst use
005Medicines for human purposes and veterinary preparations, namely, for the treatment and relief of inflammation and inflammatory diseases and disorders; Medicines for human purposes and veterinary preparations, namely, antioxidants; Medicines for human purposes and veterinary preparations, namely, preparations for the treatment of allergies, hay fever, motion sickness, dermatologic use, namely, the treatment of dermatitis, skin pigmentation diseases, treatment of cold sores, treatment and prevention of dry skin, eczema, psoriasis, acne, for the treatment of atopic skin, the treatment of sunburn, irritated skin, cracking, cracks, insect bites, minor wounds, rashes, warts, for the treatment of diseases and symptoms within the central nervous system, namely, anxiety, spasms, sleep disorders, nervousness, irritability, nerves, apprehensiveness, emotional palpitations, for the treatment of disorders and conditions involving the joints, muscles, tendons and ligaments, for the treatment of joint pain, muscle, muscle fatigue, cramps, fatigue states, for the treatment of toothache, for the treatment of infections of the mouth, for the treatment of bruises, bumps, aches, pain, fever, headaches, vitamin-based nutritional supplements and mineral supplements; Medicines for human purposes and veterinary preparations, namely, bacterial and bacteriological preparations for medical or veterinary purposes; Veterinary preparations and substances, namely, for the prevention and treatment of damaged skin and tissue, skin disorders, skincare, skin lotions; Veterinary preparations and substances to treat and control fleas and ticks on animals; Veterinary preparations and substances for treatment of intestinal bacteria and parasites in mammals; Drugs for medical purposes, namely, antibiotics and anti-infectives for the treatment and prevention of infectious diseases and obesity, fat and cholesterol control, blood sugar control and strengthening of immune system; Drugs for medical purposes for the treatment of pain, inflammation, damaged skin and tissues and wounds; Drugs for medical purposes, namely, drugs for use in treating dermatitis, eczema, psoriasis, ulcerating wounds, skin diseases, skin conditions and lesions; Pharmacological preparations for skin care; Sanitary preparations for medical use; Food supplements; Dietary supplements; Health functional food, namely, meal replacements in the form of bars, snacks, and shakes for medical purposes and for weight loss purposes; Health functional foods for therapeutic purposes and for use as nutritional supplements and dietary supplements, namely, meal replacement bars for medical use, nutritional supplements, dietary supplements; Health functional foods for therapeutic purposes and for use as nutritional supplements and dietary supplements, namely, probiotic, prebiotic or protein blends; Health functional foods containing red ginseng extracts for therapeutic purposes and for use as nutritional supplements and dietary supplements; Nutritional supplements; Food for babies; Milk sugar for pharmaceutical purposes; Infant formula; Deodorants, other than for human beings or for animals in the nature of household deodorants, air deodorants, car deodorants; Deodorants, other than for human beings or for animals, namely, deodorants for shoes, clothing and textiles; Cultures and preparations of microorganisms for medical purposes; Portable first-aid kits; Aseptic cotton; Materials for dental fillings; Disposable nappies, namely, baby diapers, adult diaper, and diapers for incontinence; Mothproofing paper; Medicated plasters; Health supplement, namely, health food supplements and dietary supplements; Health supplements for weight management, fat burning, beauty, body wellness, energy, physical performance, endurance, focus, brain stimulation, stress reduction, and overall optimal healthSECTION 8 - CANCELLED—
029Health supplement food based on vegetables, namely, non-alcoholic vegetable extracts for use as ingredients of nutritional supplements and vitamins; Health supplement food mainly based on vegetables, namely, jellies for food purposes; Health supplement food based on vegetables, namely, healthy prepared meals consisting primarily of vegetables; Health supplement food based on vegetables, namely, vegetable based snack foods; Health supplement food mainly based on fruits, namely, fruit-based snack food, fruit-based spreads; Health supplement food based on fruits, namely, non-alcoholic fruit extracts for use as ingredients of nutritional supplements and vitamins; Health supplement food mainly based on edible beans, namely, processed beans, cooked beans; Health supplement food mainly based on edible eggs, namely, processed eggs, prepared meals consisting primarily of eggs, egg-based snack foods; Health supplement food mainly based on meat, namely, preserved meat, processed meat; Health supplement food mainly based on meat, namely, prepared meals consisting primarily of meat, meat-based snack foods; Health supplement food based on milk, excluding ice milk, ice cream and frozen yogurt, namely, milk, yogurt, and dairy based beverages fortified with vitamins; Health supplement food mainly based on edible insects, not live, namely, insect-based snack foods; Health supplement food mainly based on seaweeds for food, preserved, namely, processed edible seaweed; Health supplement food mainly based on preserved fish, namely, preserved fish, prepared meals consisting primarily of preserved fish; Health functional food, namely, milk based beverages containing lactic acid bacteria; Health functional food consisting of propolis for food purposesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 23, 2026C8..CANCELLED SEC. 8 (6-YR)—
Mar 26, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 26, 2026ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Mar 26, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 26, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 17, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jun 17, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 17, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jun 17, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 17, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 17, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 17, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 7, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 6, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 7, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 5, 2020DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Mar 5, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 29, 2020IUCNNOTICE OF ALLOWANCE CANCELLED—
Jan 29, 2020D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Dec 17, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 22, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 22, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 2, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 18, 2019FIXDELECTRONIC RECORD REVIEW COMPLETE—
Sep 13, 2019ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Sep 12, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 6, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 6, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 6, 2019ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
May 10, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 4, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 4, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Apr 4, 2019CNSLSUSPENSION LETTER WRITTEN—
Apr 3, 2019CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 3, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 3, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 3, 2019ALIEASSIGNED TO LIE—
Mar 26, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 26, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 5, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 5, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 5, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 4, 2018DOCKASSIGNED TO EXAMINER—
Aug 9, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 7, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance